P033 (0007) SINGLE CENTER ANALYSIS OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA: FOCUS ON R-ABVD AND INTERIM PET

P033 (0007) SINGLE CENTER ANALYSIS OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA: FOCUS ON R-ABVD AND INTERIM PET

Bibliographic Details
Format:	Article
Language:	English
Published:	Wiley 2018-10-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000547885.35126.d2

Similar Items

P033: Clinical significance of the severity of THRLBCL-like areas in nodular lymphocyte predominant Hodgkin lymphoma
by: Irirna Shupletsova, et al.
Published: (2022-10-01)

Nodular lymphocyte-predominant Hodgkin’s lymphoma: Principles of diagnosis and treatment
by: T N Moiseeva, et al.
Published: (2015-11-01)

Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL): Early outcomes
by: Bhavin Visariya, et al.
Published: (2016-01-01)

Single center experience in patients with a diagnosis of nodular lymphocyte predominant Hodgkin lymphoma
by: Fahir Özkalemkaş, et al.
Published: (2021-03-01)

THE MORPHOLOGICAL SUBSTRATE AND IMMUNOHYSTOARCHITECTURAL PATTERNS IN NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA
by: I. A. Shupletsova, et al.
Published: (2019-03-01)

Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence
by: Arun Seshachalam, et al.
Published: (2019-12-01)

Nodular lymphocyte-predominant Hodgkin lymphoma: a rare lymphoma with isolated hepatic presentation
by: Bruno Freitas, et al.
Published: (2023-09-01)

T020: Interim PET-guided treatment of early-stage nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the GHSG HD16 and HD17 studies
by: Dennis A. Eichenauer, et al.
Published: (2022-10-01)

Nodular lymphocyte predominance Hodgkin lymphoma of the parotid gland: a case report
by: Carlos Augusto Ferreira Alves, et al.
Published: (2012-03-01)

Nodular lymphocyte-predominant Hodgkin lymphoma in a patient with Familial Mediterranean Fever
by: Marina Belia, et al.
Published: (2022-06-01)

Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Review of Current Literature and Case Discussion
by: Adarsh Sidda MD, et al.
Published: (2022-07-01)

Pitfalls in the Diagnosis of Nodular Lymphocyte Predominant Hodgkin Lymphoma: Variant Patterns, Borderlines and Mimics
by: Sheren Younes, et al.
Published: (2021-06-01)

Nodular lymphocyte predominant Hodgkin lymphoma and diphenylhydantoin: Report of a case and review of the literature
by: Shobhna Sharma, et al.
Published: (2013-01-01)

Risk of hematological malignancies in the families of patients treated for nodular lymphocyte-predominant Hodgkin lymphoma
by: Saad Akhtar, et al.
Published: (2021-02-01)

Nodular lymphocyte-predominant hodgkin lymphoma: A rare indolent tumour with recurrence at extranodal sites
by: Rabab, NB, et al.
Published: (2011)

Incidence, histology and immunohistochemistry study of nodular lymphocyte-predominant hodgkin's lymphoma in UMMC (1976-2005)
by: Wan, L.H., et al.
Published: (2007)

Minimising chemotherapy while optimising immune therapy for paediatric nodular lymphocyte-predominant Hodgkin's lymphoma
by: Roiya Farhan, MBBS, et al.
Published: (2020-12-01)

When is surgical resection alone appropriate treatment for pediatric nodular lymphocyte-predominant Hodgkin lymphoma?
by: Sarah Y Bessen, et al.
Published: (2021-06-01)

The Use of Filgrastim in Patients with Hodgkin Lymphoma Receiving ABVD
by: Adam F. Binder, et al.
Published: (2017-10-01)

Relapsed nodular lymphocyte-predominant Hodgkin lymphoma presenting as severe paraneoplastic hepatitis: a case report
by: Anthony J. Deacon, et al.
Published: (2023-06-01)

Simultaneous occurrence of Kaposi’s sarcoma and nodular lymphocyte predominant subtype of Hodgkin’s lymphoma in the same lymph node
by: Muhit Özcan, et al.
Published: (2009-12-01)

Long-term outcomes in patients with early stage nodular lymphocyte-predominant Hodgkin's lymphoma treated with radiotherapy.
by: Abhishek A Solanki, et al.
Published: (2013-01-01)

Transformation and outcome of nodular lymphocyte predominant Hodgkin lymphoma: a Finnish Nationwide population-based study
by: Ilja Kalashnikov, et al.
Published: (2021-12-01)

Two diseases in a single lymph node: nodular lymphocyte predominant hodgkin lymphoma and kaposi's sarcoma
by: E. Turan Erkek, et al.
Published: (2020-10-01)

P019: Unfavorable prognostic value of the predominance of THRLBCL-like histopathological growth patterns in nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL)
by: Elena Dorokhina, et al.
Published: (2022-10-01)

T014 (0118) MULTICENTRIC ITALIAN EXPERIENCE IN TREATMENT OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA (NLPHL) IN THE RITUXIMAB ERA
Published: (2018-10-01)

P1092: NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA (NLPHL): HISTOLOGYCAL AND CLINICAL REVIEW IN A SINGLE CENTRE.
by: E. Rámila, et al.
Published: (2022-06-01)

Treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Where Do We Stand? Where Do We Go?
by: Dennis A. Eichenauer, et al.
Published: (2023-06-01)

Rituximab plus Ifosfamide, Carboplatin and Etoposide for T-Cell/Histiocyte-Rich B-Cell Lymphoma Arising in Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma
by: Hyung-Chul Park, et al.
Published: (2012-08-01)

P076 (0056) CLINICAL CHARACTERISTICS AND TREATMENT OUTCOME OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN‘S LYMPHOMA WITH THRLBCL-LIKE PATTERNS
Published: (2018-10-01)

Rituximab-Containing Risk-Adapted Treatment Strategy in Nodular Lymphocyte Predominant Hodgkin Lymphoma: 7-Years Follow-Up
by: Novella Pugliese, et al.
Published: (2021-04-01)

MEF2B is the ideal immunohistochemical marker to highlight neoplastic LP cells in nodular lymphocyte‐predominant Hodgkin lymphoma
by: Alireza Torabi, et al.
Published: (2023-05-01)

Sarcoid like reaction in a child with nodular lymphocytic predominant Hodgkin lymphoma following chemotherapy: A case report
by: Kasi Bharathi Thatikonda, et al.
Published: (2022-01-01)

Outcomes of Patients with Positive Interim Positron Emission Tomography (PET) Continuing ABVD in the Clinical Setting
by: Serena Zheng, et al.
Published: (2023-03-01)

Microenvironmental immune cell alterations across the spectrum of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma
by: Christos Panayi, et al.
Published: (2023-10-01)

Meningeal Relapse of Nodular Lymphocyte Predominant Hodgkin Lymphoma Transformed to T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Case Report
by: Paolo Salvioni Chiabotti, et al.
Published: (2020-09-01)

P077 (0060) COMPARISON IMMUNOARCHITECTURAL PATTERNS OF PRIMARY, EXTRANODAL AND BONE MARROW LESIONS IN NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA
Published: (2018-10-01)

P088: Case series of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Tanzania. A common entity in East Africa?
by: Atukuzwe Kahakwa, et al.
Published: (2022-10-01)

P012: Nodular Lymphocyte-predominant Hodgkin Lymphoma a rare disease with good prognosis: a retrospective multicenter experience
by: Francesca Pierdomenico, et al.
Published: (2022-10-01)

Anti-Ma-associated paraneoplastic cerebellar degeneration in a patient with nodular lymphocyte-predominant Hodgkin lymphoma: a case report
by: Ryoma Inui, et al.
Published: (2020-09-01)